Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Clinical trial NCT05065216 · RECRUITING

Trial details

NCT number: NCT05065216
Sponsor: DiaMedica Therapeutics Inc
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Stroke Ischemic Stroke Stroke

Start date: 2021-11-07
Primary completion: 2026-12-01
Enrollment: 728

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.